Skip Navigation LinksHome > December 2012 - Volume 18 - Issue > Long‐Term Efficacy of Adalimumab for Treatment of Moderately...
Inflammatory Bowel Diseases:
Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13-15, 2012 Hollywood, Florida: Clinical Poster Presentations

Long‐Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis: P‐19

Colombel, Jean‐Frédéric1; Sandborn, William2; Wolf, Doug3; Panaccione, Remo4; Lazar, Andreas5; Kron, Martina5; Robinson, Anne6; Thakkar, Roopal6

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.